What now for aspirin and cancer prevention?

被引:12
作者
Baron, JA [1 ]
机构
[1] Dartmouth Coll Sch Med, Dept Med, Lebanon, NH 03756 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2004年 / 96卷 / 01期
关键词
D O I
10.1093/jnci/djh027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4 / 5
页数:2
相关论文
共 26 条
[1]  
Anderson KE, 2002, J NATL CANCER I, V94, P1168, DOI 10.1093/jnci/94.15.1168
[2]   Pancreatic cancer biology and genetics [J].
Bardeesy, N ;
DePinho, RA .
NATURE REVIEWS CANCER, 2002, 2 (12) :897-909
[3]  
Baron JA, 2003, PROG EXP TUMOR RES, V37, P1
[4]   A randomized trial of aspirin to prevent colorectal adenomas [J].
Baron, JA ;
Cole, BF ;
Sandler, RS ;
Haile, RW ;
Ahnen, D ;
Bresalier, R ;
McKeown-Eyssen, G ;
Summers, RW ;
Rothstein, R ;
Burke, CA ;
Snover, DC ;
Church, TR ;
Allen, JI ;
Beach, M ;
Beck, GJ ;
Bond, JH ;
Byers, T ;
Greenberg, ER ;
Mandel, JS ;
Marcon, N ;
Mott, LA ;
Pearson, L ;
Saibil, F ;
van Stolk, RU .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10) :891-899
[5]   Daily soluble aspirin and prevention of colorectal adenoma recurrence: One-year results of the APACC trial [J].
Benamouzig, R ;
Deyra, J ;
Martin, A ;
Girard, B ;
Jullian, E ;
Piednoir, B ;
Couturier, D ;
Coste, T ;
Little, J ;
Chaussade, S .
GASTROENTEROLOGY, 2003, 125 (02) :328-336
[6]  
Coogan PF, 2000, CANCER EPIDEM BIOMAR, V9, P119
[7]   TREATMENT OF COLONIC AND RECTAL ADENOMAS WITH SULINDAC IN FAMILIAL ADENOMATOUS POLYPOSIS [J].
GIARDIELLO, FM ;
HAMILTON, SR ;
KRUSH, AJ ;
PIANTADOSI, S ;
HYLIND, LM ;
CELANO, P ;
BOOKER, SV ;
ROBINSON, CR ;
OFFERHAUS, GJA .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (18) :1313-1316
[8]   Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum:: a meta-analysis -: art. no. 28 [J].
González-Pérez, A ;
Rodríguez, LAG ;
López-Ridaura, R .
BMC CANCER, 2003, 3 (1)
[9]   Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the US Preventive Services Task Force [J].
Hayden, M ;
Pignone, M ;
Phillips, C ;
Mulrow, C .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (02) :161-172
[10]   Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers [J].
Hopper, JL ;
Baron, JA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (13) :1010-1011